Concert Pharmaceuticals clinical trials

Acquired by Sun Pharmaceutical Industries Limited, Mar 2023 · source ↗

The registry lists 33 studies whose lead sponsor is Concert Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 9, 2024.

Studies

Recruiting first, then most recently updated. Showing 33 of 33. All Sun Pharmaceutical Industries Limited studies →

• A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia AreataCompletedNCT04784533Phase 2

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With SchizophreniaCompletedNCT04158687Phase 2

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)CompletedNCT04797650Phase 3

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)CompletedNCT04518995Phase 3

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia AreataCompletedNCT03941548Phase 2

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia AreataCompletedNCT03811912Phase 2

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543CompletedNCT05467722Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543CompletedNCT05468749Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy SubjectsCompletedNCT05478772Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy VolunteersCompletedNCT05467696Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy SubjectsCompletedNCT05467709Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia AreataCompletedNCT03137381Phase 2

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health VolunteersCompletedNCT05192369Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsCompletedNCT01487109Phase 2

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult SubjectsCompletedNCT04843540Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult SubjectsCompletedNCT04743414Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female SubjectsCompletedNCT04309643Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male VolunteersCompletedNCT04092712Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy VolunteersCompletedNCT03830463Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Food Effect Study of CTP-543 in Healthy VolunteersCompletedNCT03880136Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Multiple Ascending Dose Study of CTP-692 in Healthy VolunteersCompletedNCT03880253Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy VolunteersCompletedNCT03778320Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Open-Label Crossover Study Comparing CTP-543 to Jakafi®CompletedNCT02960945Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy SubjectsCompletedNCT02777008Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656CompletedNCT02599792Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Food Effect Study of CTP-656 in Healthy Male VolunteersCompletedNCT02680249Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Multiple Ascending Dose Study in Healthy VolunteersCompletedNCT02404922Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy SubjectsCompletedNCT02392702Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• A Safety and Tolerability Study of CTP-730 in Healthy VolunteersCompletedNCT02239081Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and PharmacodynamicsCompletedNCT02215499Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to ReyatazCompletedNCT01458769Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney DiseaseCompletedNCT01460199Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited

• Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499CompletedNCT01328821Phase 1

  Sponsor listed in the registry: Concert Pharmaceuticals · First submitted before Concert Pharmaceuticals became part of Sun Pharmaceutical Industries Limited